Moderna to join S&P 500, shares jump after hours

Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevating its market capitalization to about $100 billion.

Reuters
Britain's AstraZeneca said last December it would acquire U.S. biotech Alexion in a $39 billion deal.
Moderna Inc will join the S&P 500 index as of the start of trading on July 21, replacing Alexion Pharmaceuticals, S&P Dow Jones Indices said in a statement on Thursday.

Moderna shares rose 6% in extended trade after the announcement. The COVID-19 vaccine maker's stock has surged over 150% this year, elevating its market capitalization to about $100 billion.

Britain's AstraZeneca said last December it would acquire U.S. biotech Alexion in a $39 billion deal.

ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Moderna to join S&P 500, shares jump after hours
Text Size:AAA
Success
This article has been saved

*

+